Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Structure of the blood-brain barrier
-
1. The blood-brain barrier in Alzheimer’s disease
- Dr. Anika Hartz
-
2. Tanycytes allow a tight BBB in the median eminence
- Prof. Esteban Rodriguez
- Dr. Juan Luis Blazquez
- Dr. Montserrat Guerra
- Nutrient transport
-
3. Blood-brain barrier ion transport
- Prof. Martha O'Donnell
- Peptides and proteins
-
4. Ingestive peptides
- Prof. William Banks
-
5. Blood-brain barrier in health and disease
- Prof. Thomas Davis
- Overcoming the blood-brain barrier obstacle
-
6. Expression vs. function of ABC transporters at the blood-brain barrier
- Prof. Jean-Michel Scherrmann
-
7. The blood-brain barrier and CNS drug development
- Dr. Danica Stanimirovic
- Diseases involving the blood-brain barrier
-
9. Inflammation and immune cell entry to the central nervous system
- Prof. Serge Rivest
-
11. Ischemic blood-brain barrier and Alzheimer's amyloid plaques development
- Prof. Ryszard Pluta
- Latest Developments in the Field
-
12. MRI approaches for neurovascular imaging
- Dr. Rick Dijkhuizen
-
13. Brain-gut interactions in obesity 1
- Prof. Weihong Pan
-
14. Brain-gut interactions in obesity 2
- Prof. Weihong Pan
- Archived Lectures *These may not cover the latest advances in the field
-
15. Neurotrophins and the BBB
- Prof. Weihong Pan
-
16. Vasoactive peptides and the blood-brain barrier
- Prof. Maria Deli
- Prof. Bela Kis
-
17. In vivo systems
- Prof. Quentin Smith
-
18. CNS-drug design
- Prof. Quentin Smith
-
20. Stroke and the BBB
- Prof. Marilyn Cipolla
-
21. Barrier mechanisms in the developing brain: mechanisms and misunderstandings
- Prof. Norman Saunders
-
22. Barrier mechanisms in the developing brain: protection or vulnerability?
- Prof. Norman Saunders
-
23. In vitro models of the blood-brain barrier
- Prof. Pierre-Olivier Couraud
-
24. Glucose transport across the blood-brain barrier
- Prof. Luc Leybaert
-
25. The blood-brain barrier and brain tumors
- Dr. Olaf van Tellingen
-
26. Cellular composition of the blood-brain barrier
- Prof. N. Joan Abbott
-
27. Features of mammalian CNS barrier systems
- Prof. Conrad Johanson
Printable Handouts
Navigable Slide Index
- Introduction
- Two hypotheses
- Barrier mechanisms in the brain
- BBB enriched tight junction molecules
- Tight junction in lateral ventricular choroid plexus
- Barrier mechanisms in the developing brain
- Transfer of metabolically important molecules
- Oldendorf BUI uptake method
- BBB transport of arginine
- BBB permeability in newborn and adult rabbits
- BUI of amino acids in newborn and adult rats
- Mouse blood-brain barrier transcriptome
- Solute carrier family
- Transport in the developing mouse blood-CSF
- Distribution of GLUT1 in embryonic brain
- GLUT1 in human fetal cerebral blood vessels
- GLUT1 in human fetal choroid plexus
- Developmental expression of MCT1 and MCT2
- Summary of influx mechanisms
- Protein immunostaining in choroid plexus
- Plasma proteins and lipid-insoluble probes
- BDA and albumin labeled P9 Monodelphis
- Effects of plasma protein on CSF protein
- Bidirectional transfer of biotin dextran
- Transport of plasma proteins and dextrans
- Altered expression in the mouse choroid plexus
- Albumin in embryos and adults
- Expression of Sparc/Gypa/Gypc
- Immunocytochemistry of GYPA
- Immunocytochemistry of SPARC
- Model of albumin transport
- Albumin potential as a drug delivery aid
- Efflux mechanisms in the embryo and fetus
- Distribution of brain ABC transporters
- P-glycoprotein of brain microvessels in adult
- P-glycoprotein of human fetal brain
- Role of BCRP in fetal protection
- mRNA in choroid plexus (qPCR)
- BCRP in rat cortex
- BCRP in rat choroid plexus
- BCRP in embryonic and adult rat
- ABC gene expression in cerebral endothelial cells
- ABC gene expression in mouse choroid plexus
- ABC gene expression in adults and embryos
- Transporters in developing choroid plexus
- Further studies
- Practical consequences
- Developmental toxicity of industrial chemicals
- Consequences of prenatal toxin exposure
- Drugs in pregnancy and lactation
- Need for systematic studies
- Exposure to environmental toxins
- Toxicological properties of heavy metals
- Excitotoxic amino acids
- Inflammation during brain development (1)
- Inflammation during brain development (2)
- Short term effect on white matter tract volume
- Long term effect of prolonged inflammation
- Biotin ethylenediamine: adult rat external capsule
- LPS injected in neonatal rat and claudin-5
- Vulnerability of the developing brain summary
- Overall summary
- Acknowledgements
- Reference & reading list
Topics Covered
- The brain develops within a well-defined internal environment
- The properties of this internal environment are determined by transporters in the cellular interfaces between the blood, brain and cerebrospinal fluid
- The transporters are effective because the intercellular spaces between the cells in the interfaces are sealed by tight junctions
- The transporters are both influx and efflux and many are active very early in brain development
- Although brain barrier mechanisms are present very early in development they are vulnerable to pathological conditions e.g. inflammation, which may result in barrier dysfunction and damage to the fragile developing brain
- These mechanisms thus provide protection and a stable internal environment, but some may render the developing brain more vulnerable e. g. inward transport of toxins such as mercury via a normal amino acid transporter
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Saunders, N. (2014, January 13). Barrier mechanisms in the developing brain: protection or vulnerability? [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/SDSJ2758.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Norman Saunders has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Barrier mechanisms in the developing brain: protection or vulnerability?
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Norman Saunders.
I run a research laboratory in the University of Melbourne in Australia.
This is the second of 2 talks on barrier mechanisms in the developing brain.
In the first talk I said that I would deal with 2 hypotheses,
which are shown in this next slide.
0:20
The first hypothesis is that the brain develops within a well controlled internal environment
that is determined by mechanisms in brain barrier interfaces.
And the second hypothesis is that disturbance of brain barrier mechanisms in the embryo
may have immediate or long-term consequences for brain development
and may underlie some developmental and adult neurological disorders.
In that first talk I dealt mainly with the first hypothesis.
In this second talk I shall give you additional information,
much of it only recently published, which bears on the notion
that the brain develops within a well controlled internal environment.
I'd like to begin with an update on the information that I gave you in that first talk
about the integrity of tight junctions in blood vessels in the developing brain.
1:06
This slide is a reminder of the main barrier interfaces in the adult and developing brain.
In addition to the morphological evidence outlined in the first talk,
there is now molecular evidence which reinforces the finding
that tight junctions in the blood-brain and blood-CSF barriers
are functionally effective even in the embryo and neonate.
Molecular expression studies of Daneman and his colleagues in Stanford University
have shown that the junctional proteins occludin and numerous claudins
are expressed in postnatal mouse cerebral blood vessels within a few days of birth,
and that's illustrated in the next slide.
Hide